Amber Sapp, NP

NPI: 1568715340
Total Payments
$4,048
2024 Payments
$1,788
Companies
28
Transactions
205
Medicare Patients
1,990
Medicare Billing
$177,292

Payment Breakdown by Category

Food & Beverage$3,849 (95.1%)
Education$199.25 (4.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,849 203 95.1%
Education $199.25 2 4.9%

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim Pharmaceuticals, Inc. $542.66 26 $0 (2024)
GlaxoSmithKline, LLC. $532.59 35 $0 (2024)
AstraZeneca Pharmaceuticals LP $505.12 29 $0 (2024)
Insmed, Inc. $291.12 18 $0 (2024)
Regeneron Healthcare Solutions, Inc. $274.72 9 $0 (2024)
United Therapeutics Corporation $272.62 12 $0 (2024)
Janssen Pharmaceuticals, Inc $242.93 13 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $161.53 9 $0 (2024)
Mallinckrodt Hospital Products Inc. $155.62 3 $0 (2024)
GENZYME CORPORATION $141.48 5 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,788 81 AstraZeneca Pharmaceuticals LP ($261.90)
2023 $1,064 54 Insmed, Inc. ($158.86)
2022 $884.65 51 AstraZeneca Pharmaceuticals LP ($157.92)
2021 $310.94 19 Boehringer Ingelheim Pharmaceuticals, Inc. ($101.87)

All Payment Transactions

205 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
12/17/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Education In-kind items and services $99.26 General
Category: INFLAMMATION AND IMMUNOLOGY
12/05/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $15.13 General
Category: INFLAMMATION AND IMMUNOLOGY
12/03/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $14.16 General
Category: Respiratory
12/02/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $18.63 General
Category: RESPIRATORY
11/25/2024 Merck Sharp & Dohme LLC WINREVAIR (Biological) Food and Beverage In-kind items and services $24.27 General
Category: CARDIOVASCULAR
11/25/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $17.28 General
Category: RESPIRATORY
11/12/2024 GlaxoSmithKline, LLC. AREXVY (Drug), TRELEGY ELLIPTA Food and Beverage In-kind items and services $16.14 General
Category: RESPIRATORY
11/08/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $29.28 General
Category: RESPIRATORY
11/07/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $15.03 General
Category: IMMUNOLOGY
11/04/2024 United Therapeutics Corporation REMODULIN (Drug), ORENITRAM Food and Beverage In-kind items and services $29.76 General
Category: Pulmonary Arterial Hypertension
11/01/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $19.06 General
Category: RESPIRATORY
10/29/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $16.36 General
Category: Respiratory
10/28/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $19.25 General
Category: Immunology
10/21/2024 Merck Sharp & Dohme LLC WINREVAIR (Biological) Food and Beverage In-kind items and services $20.25 General
Category: CARDIOVASCULAR
10/10/2024 United Therapeutics Corporation TYVASO (Drug) Food and Beverage In-kind items and services $28.51 General
Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease
10/09/2024 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $26.86 General
Category: IMMUNOLOGY
10/08/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $22.22 General
Category: RESPIRATORY
10/08/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $20.06 General
Category: RESPIRATORY
09/25/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $10.72 General
Category: IMMUNOLOGY
09/24/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug), AREXVY Food and Beverage In-kind items and services $17.13 General
Category: RESPIRATORY
09/14/2024 Electromed, Inc. SMARTVEST (Device) Food and Beverage Cash or cash equivalent $13.38 General
Category: HFCWO
09/11/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $20.44 General
Category: INFLAMMATION AND IMMUNOLOGY
09/06/2024 Boehringer Ingelheim Pharmaceuticals, Inc. OFEV (Drug) Food and Beverage In-kind items and services $10.91 General
Category: RESPIRATORY
09/05/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $25.69 General
09/04/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $7.98 General
Category: RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 604 865 $136,126 $52,020
2022 10 644 814 $97,839 $44,456
2021 10 460 717 $101,499 $41,142
2020 6 282 713 $113,516 $39,674
Total Patients
1,990
Total Services
3,109
Medicare Billing
$177,292
Procedure Codes
38

All Medicare Procedures & Services

38 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 297 443 $90,625 $34,869 38.5%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 52 142 $19,880 $7,360 37.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 60 67 $8,448 $3,763 44.5%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 27 27 $7,020 $2,221 31.6%
90694 Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage Office 2023 14 14 $1,050 $1,026 97.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 25 27 $2,564 $898.25 35.0%
71046 X-ray of chest, 2 views Office 2023 44 45 $3,234 $742.54 23.0%
94618 Test for exercise-induced lung stress Office 2023 24 25 $1,361 $366.64 26.9%
G0008 Administration of influenza virus vaccine Office 2023 14 14 $364.00 $356.72 98.0%
96372 Injection of drug or substance under skin or into muscle Office 2023 14 21 $840.00 $170.05 20.2%
36415 Insertion of needle into vein for collection of blood sample Office 2023 19 20 $500.00 $168.00 33.6%
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg Office 2023 14 20 $240.00 $79.12 33.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 202 265 $39,750 $20,875 52.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 206 240 $24,000 $12,486 52.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 57 120 $16,800 $5,523 32.9%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 22 23 $5,980 $2,084 34.8%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 27 28 $1,820 $946.35 52.0%
71046 X-ray of chest, 2 views Office 2022 51 57 $4,086 $910.02 22.3%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 18 19 $2,223 $837.82 37.7%
94618 Test for exercise-induced lung stress Office 2022 28 28 $2,296 $587.38 25.6%
96372 Injection of drug or substance under skin or into muscle Office 2022 16 17 $680.00 $138.16 20.3%
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg Office 2022 17 17 $204.00 $68.15 33.4%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 112 308 $43,120 $14,841 34.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 102 112 $16,800 $9,438 56.2%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 32 75 $15,750 $5,201 33.0%

About Amber Sapp, NP

Amber Sapp, NP is a Family healthcare provider based in Albany, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2012. The National Provider Identifier (NPI) number assigned to this provider is 1568715340.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amber Sapp, NP has received a total of $4,048 in payments from pharmaceutical and medical device companies, with $1,788 received in 2024. These payments were reported across 205 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,849).

As a Medicare-enrolled provider, Sapp has provided services to 1,990 Medicare beneficiaries, totaling 3,109 services with total Medicare billing of $177,292. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Albany, GA
  • Active Since 10/18/2012
  • Last Updated 02/06/2025
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1568715340

Products in Payments

  • OFEV (Drug) $508.30
  • DUPIXENT (Biological) $416.20
  • TRELEGY ELLIPTA (Drug) $378.13
  • Arikayce (Drug) $291.12
  • XARELTO (Drug) $242.93
  • TYVASO (Drug) $190.00
  • AIRSUPRA (Drug) $169.29
  • Adempas (Drug) $161.53
  • ACTHAR (Biological) $155.62
  • TEZSPIRE (Biological) $140.86
  • BREZTRI (Drug) $101.64
  • NUCALA (Biological) $90.62
  • Prolastin-C Liquid (Biological) $80.32
  • UPTRAVI (Drug) $78.89
  • SMARTVEST (Device) $74.23
  • BEVESPI AEROSPHERE (Drug) $65.64
  • GLASSIA (Biological) $54.10
  • AREXVY (Drug) $51.99
  • REMODULIN (Drug) $50.81
  • Wakix (Drug) $50.73

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Albany